PUBLISHER: The Business Research Company | PRODUCT CODE: 1947061
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947061
Remote cardiac monitoring utilizes technology to continuously track a patient's heart activity from a distance, typically through wearable devices or implanted monitors. These devices transmit real-time data on heart rhythms and other vital signs to healthcare providers for analysis and prompt intervention. The goal of remote cardiac monitoring is to deliver ongoing and precise cardiac care, facilitating early detection of arrhythmias, heart attacks, and other cardiovascular issues. This approach aims to enhance patient outcomes and reduce the necessity for frequent in-person visits.
The primary components of remote cardiac monitoring include devices, software, and associated services. Remote cardiac monitoring devices encompass wearable or implantable technologies that monitor and transmit real-time heart activity data to healthcare providers, enabling continuous remote monitoring and management of cardiac health. These devices are employed in monitoring conditions such as bradycardia, tachycardia, atrial and ventricular fibrillation, among others. End users of remote cardiac monitoring include hospitals, clinics, emergency settings, homecare environments, and other healthcare facilities.
Tariffs are impacting the remote cardiac monitoring market by increasing costs of imported sensors, semiconductors, communication modules, and wearable device components used in monitoring devices and platforms. Healthcare providers in North America and Europe are most affected due to reliance on imported electronics, while Asia-Pacific faces pricing pressure on device manufacturing. These tariffs are increasing device costs and slowing large-scale deployment. However, they are also encouraging domestic electronics production, regional device assembly, and innovation in cost-efficient remote cardiac monitoring solutions.
The remote cardiac monitoring market research report is one of a series of new reports from The Business Research Company that provides remote cardiac monitoring market statistics, including remote cardiac monitoring industry global market size, regional shares, competitors with a remote cardiac monitoring market share, detailed remote cardiac monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the remote cardiac monitoring industry. This remote cardiac monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The remote cardiac monitoring market size has grown exponentially in recent years. It will grow from $7.57 billion in 2025 to $9.29 billion in 2026 at a compound annual growth rate (CAGR) of 22.7%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, expansion of telehealth services, rising adoption of wearable health devices, availability of mobile cardiac monitoring solutions, growing acceptance of remote patient monitoring.
The remote cardiac monitoring market size is expected to see exponential growth in the next few years. It will grow to $20.58 billion in 2030 at a compound annual growth rate (CAGR) of 22.0%. The growth in the forecast period can be attributed to increasing demand for proactive cardiac care, expansion of digital health infrastructure, rising focus on reducing hospital readmissions, growing investments in remote monitoring technologies, advancements in real-time cardiac analytics. Major trends in the forecast period include increasing adoption of wearable cardiac monitoring devices, rising use of cloud-based monitoring platforms, growing integration of ai-driven arrhythmia detection, expansion of home-based cardiac monitoring programs, enhanced focus on continuous patient monitoring.
The increasing prevalence of cardiovascular diseases is expected to propel the growth of the remote cardiac monitoring market going forward. Cardiovascular diseases encompass disorders of the heart and blood vessels, including coronary artery disease, heart failure, arrhythmias, and hypertension. Their prevalence is rising due to factors such as unhealthy diets, physical inactivity, growing rates of obesity and diabetes, and aging populations. Remote cardiac monitoring plays a critical role in managing these conditions by enabling continuous, real-time tracking of heart health, allowing for early detection, timely intervention, and improved disease management. For instance, in October 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health institute, 919,032 people died from cardiovascular disease in 2023, accounting for approximately 1 in every 3 deaths. Coronary heart disease was the most common type, causing 371,506 deaths in 2022. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the remote cardiac monitoring market.
Major companies operating in the remote cardiac monitoring market are focusing on integrating AI-powered solutions to improve diagnostic precision and enable timely interventions. AI-enabled heart monitoring systems employ machine learning algorithms to continuously analyze heart rhythms, identifying irregularities such as arrhythmias or early warning signs of heart attacks, and notifying healthcare providers for prompt action. For instance, in January 2024, AliveCor, a US-based health technology company, launched the KardiaMobile 6L, a portable six-lead ECG device that leverages AI algorithms to detect key heart conditions, including atrial fibrillation (AFib). The device pairs with a mobile app, providing real-time data transmission to healthcare providers and reinforcing AliveCor's commitment to advancing remote cardiac monitoring through AI-driven, user-friendly technology.
In April 2025, CardioOne Inc., a US-based provider of advanced cardiac care solutions and cardiovascular monitoring technologies, acquired CardioDiagnostics for an undisclosed amount. Through this acquisition, CardioOne aims to strengthen its technological capabilities in remote cardiac monitoring and diagnostic services, broadening its portfolio of innovative cardiology solutions. CardioDiagnostics Holdings Inc. is a US-based company that provides remote cardiac monitoring systems and diagnostic services to support early detection and continuous management of cardiovascular conditions.
Major companies operating in the remote cardiac monitoring market are Abbott Laboratories, Medtronic Plc, Koninklijke Philips N.V., GE Healthcare, ZOLL Medical Corporation, Boston Scientific Corporation, Hill-Rom Holdings Inc., Masimo Corporation, Biotronik SE, Nihon Kohden Corporation, Irhythm Technologies Inc., BioTelemetry Inc., Spacelabs Healthcare Inc., AMC Health, Huma Limited, AliveCor Inc., Contec Medical Systems Co. Ltd., InfoBionic Inc., Bardy Diagnostics Inc., ChroniSense Medical Ltd., Cardiomo Care Inc., Vitls Inc.
North America was the largest region in the remote cardiac monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the remote cardiac monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the remote cardiac monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The remote cardiac monitoring market consists of revenues earned by entities by providing services such as continuous ECG monitoring, mobile cardiac telemetry, holter monitoring, and wearable device integration. The market value includes the value of related goods sold by the service provider or included within the service offering. The Information technology market also includes sales of implantable loop recorders, remote pacemaker and ICD monitors, cardiac event recorders and related services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Remote Cardiac Monitoring Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses remote cardiac monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for remote cardiac monitoring ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The remote cardiac monitoring market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.